References
1. Demirkan FG, Doğan S, Kalyoncu Uçar A, Sönmez HE, Aktay Ayaz N. Systemic lupus erythematosus complicated with Castleman disease: a case-based review. Rheumatology international. 2021;41(2):475-9.
2. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and rheumatism. 2012;64(8):2677-86.
3. Gillmore R, Sin WY. Systemic lupus erythematosus mimicking lymphoma: the relevance of the clinical background in interpreting imaging studies. BMJ case reports. 2014;2014.
4. Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA. Histology-Independent Signature Distinguishes Kikuchi-Fujimoto Disease/Systemic Lupus Erythematosus-Associated Lymphadenitis From Benign and Malignant Lymphadenopathies. American journal of clinical pathology. 2020;154(2):215-24.
5. Xia JY, Chen XY, Xu F, Yang Y, Wang HY, Xue J. A case report of systemic lupus erythematosus combined with Castleman’s disease and literature review. Rheumatology international. 2012;32(7):2189-93.
6. De Marchi G, De Vita S, Fabris M, Scott CA, Ferraccioli G. Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica. 2004;89(4):Ecr03.
7. Van de Voorde K, De Raeve H, De Block CE, Van Regenmortel N, Van Offel JF, De Clerck LS, et al. Atypical systemic lupus erythematosus or Castleman’s disease. Acta clinica Belgica. 2004;59(3):161-4.
8. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathology international. 2000;50(4):304-12.
9. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):670-83.
10. Castleman B, Towne VW. Case records of the Massachusetts General Hospital: Case No. 40231. The New England journal of medicine. 1954;250(23):1001-5.
11. Kessler E. Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer. 1985;56(10):2446-51.
12. van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood advances. 2020;4(23):6039-50.
13. Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, Yamane N, et al. Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman’ disease: a clinicopathologic study of five cases. Pathology, research and practice. 1997;193(8):565-71.
14. Zhang L, Jiao L, Wang SJ. Successful Treatment with Rituximab in a Patient with Castleman’s Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia. Chinese medical journal. 2015;128(18):2551-2.
Table 1. Laboratory parameters of the patient